Application 219660

Type
NDA
Sponsor
APOTEX

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
002RuxolitinibRuxolitinibTABLET; ORAL10MGNoNo
003RuxolitinibRuxolitinibTABLET; ORAL15MGNoNo
004RuxolitinibRuxolitinibTABLET; ORAL2MGNoNo

Documents

DocumentSubmission typeDate
84285ORIG 2025-11-24